FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2433636306> ?p ?o ?g. }

• W2433636306 endingPage "340" @default.
• W2433636306 startingPage "334" @default.
• W2433636306 abstract "There is poor agreement between observers of equine neurological gait abnormalities using the modified Mayhew grading scale.To stimulate a dose-dependent ataxia in horses through xylazine administration and identify quantifiable relevant gait parameters.Balanced, randomised, 2-way crossover design.Eight horses were assessed before and after administration of xylazine (low dose and high dose). Gait analyses performed before and after xylazine administration included: 1) kinematic data collected on an equine high-speed treadmill (flat and 10% decline) and from accelerometers placed on head and sacrum; and 2) kinetic data collected on a force plate.All horses developed dose-dependent ataxia. Horses developed a dose-dependent increased stride time, stride length, and time of contact (P<0.0001), and a decreased stride frequency (P<0.0002) after administration of xylazine. Although pelvic acceleration increased in the mediolateral direction (P<0.05) in horses walked on the treadmill, this movement decreased when walking over ground after administration of xylazine (P<0.05). Furthermore, centre of pressure and path length indices changed significantly in horses following administration of xylazine (P<0.05).This study examined one breed of horse (Arabian), all of similar height and weight. Accelerometers were attached to skin, not bone; no correction was made for artefacts from skin displacement. The sedative drug effect is of certain duration, limiting the data collection period.Administration of xylazine induced a dose-dependent ataxia in horses and resulted in significant changes of gait parameters, pelvic accelerations, and stabilographic variables, some of which changed in a dose-dependent fashion. Some of the altered gait parameters in this model were probably a result of overall slowing down of the stride cycle secondary to the sedative effect. Continued efforts to discover and evaluate quantifiable gait parameters that are susceptible to change following development of clinical neurological disease in horses is warranted." @default.
• W2433636306 created "2016-06-24" @default.
• W2433636306 creator A5009513244 @default.
• W2433636306 creator A5018062734 @default.
• W2433636306 creator A5035439141 @default.
• W2433636306 creator A5077276691 @default.
• W2433636306 creator A5086103638 @default.
• W2433636306 date "2016-07-23" @default.
• W2433636306 modified "2023-10-14" @default.
• W2433636306 title "Objective assessment of gait in xylazine-induced ataxic horses" @default.
• W2433636306 cites W1863297596 @default.
• W2433636306 cites W1954902434 @default.
• W2433636306 cites W1972641475 @default.
• W2433636306 cites W1976167702 @default.
• W2433636306 cites W1983606887 @default.
• W2433636306 cites W1990840758 @default.
• W2433636306 cites W2009100414 @default.
• W2433636306 cites W2025340100 @default.
• W2433636306 cites W2036353803 @default.
• W2433636306 cites W2054678763 @default.
• W2433636306 cites W2055918655 @default.
• W2433636306 cites W2059869772 @default.
• W2433636306 cites W2094502082 @default.
• W2433636306 cites W2101346916 @default.
• W2433636306 cites W2115104053 @default.
• W2433636306 cites W2129716793 @default.
• W2433636306 cites W2136812195 @default.
• W2433636306 cites W2141381874 @default.
• W2433636306 cites W2142057717 @default.
• W2433636306 cites W2147295470 @default.
• W2433636306 cites W2151838292 @default.
• W2433636306 cites W2169951123 @default.
• W2433636306 cites W2170645579 @default.
• W2433636306 cites W2487873231 @default.
• W2433636306 doi "https://doi.org/10.1111/evj.12602" @default.
• W2433636306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27296204" @default.
• W2433636306 hasPublicationYear "2016" @default.
• W2433636306 type Work @default.
• W2433636306 sameAs 2433636306 @default.
• W2433636306 citedByCount "4" @default.
• W2433636306 countsByYear W24336363062018 @default.
• W2433636306 countsByYear W24336363062019 @default.
• W2433636306 countsByYear W24336363062021 @default.
• W2433636306 crossrefType "journal-article" @default.
• W2433636306 hasAuthorship W2433636306A5009513244 @default.
• W2433636306 hasAuthorship W2433636306A5018062734 @default.
• W2433636306 hasAuthorship W2433636306A5035439141 @default.
• W2433636306 hasAuthorship W2433636306A5077276691 @default.
• W2433636306 hasAuthorship W2433636306A5086103638 @default.
• W2433636306 hasBestOaLocation W24336363061 @default.
• W2433636306 hasConcept C118552586 @default.
• W2433636306 hasConcept C141071460 @default.
• W2433636306 hasConcept C151730666 @default.
• W2433636306 hasConcept C151800584 @default.
• W2433636306 hasConcept C173906292 @default.
• W2433636306 hasConcept C18007350 @default.
• W2433636306 hasConcept C1862650 @default.
• W2433636306 hasConcept C2779591255 @default.
• W2433636306 hasConcept C2779771469 @default.
• W2433636306 hasConcept C2780762169 @default.
• W2433636306 hasConcept C2780795376 @default.
• W2433636306 hasConcept C2780906641 @default.
• W2433636306 hasConcept C2781464450 @default.
• W2433636306 hasConcept C42219234 @default.
• W2433636306 hasConcept C71924100 @default.
• W2433636306 hasConcept C86803240 @default.
• W2433636306 hasConcept C99508421 @default.
• W2433636306 hasConceptScore W2433636306C118552586 @default.
• W2433636306 hasConceptScore W2433636306C141071460 @default.
• W2433636306 hasConceptScore W2433636306C151730666 @default.
• W2433636306 hasConceptScore W2433636306C151800584 @default.
• W2433636306 hasConceptScore W2433636306C173906292 @default.
• W2433636306 hasConceptScore W2433636306C18007350 @default.
• W2433636306 hasConceptScore W2433636306C1862650 @default.
• W2433636306 hasConceptScore W2433636306C2779591255 @default.
• W2433636306 hasConceptScore W2433636306C2779771469 @default.
• W2433636306 hasConceptScore W2433636306C2780762169 @default.
• W2433636306 hasConceptScore W2433636306C2780795376 @default.
• W2433636306 hasConceptScore W2433636306C2780906641 @default.
• W2433636306 hasConceptScore W2433636306C2781464450 @default.
• W2433636306 hasConceptScore W2433636306C42219234 @default.
• W2433636306 hasConceptScore W2433636306C71924100 @default.
• W2433636306 hasConceptScore W2433636306C86803240 @default.
• W2433636306 hasConceptScore W2433636306C99508421 @default.
• W2433636306 hasFunder F4320310576 @default.
• W2433636306 hasIssue "3" @default.
• W2433636306 hasLocation W24336363061 @default.
• W2433636306 hasLocation W24336363062 @default.
• W2433636306 hasOpenAccess W2433636306 @default.
• W2433636306 hasPrimaryLocation W24336363061 @default.
• W2433636306 hasRelatedWork W1967416733 @default.
• W2433636306 hasRelatedWork W2001660323 @default.
• W2433636306 hasRelatedWork W2057857675 @default.
• W2433636306 hasRelatedWork W2791152132 @default.
• W2433636306 hasRelatedWork W2805310348 @default.
• W2433636306 hasRelatedWork W2912752806 @default.
• W2433636306 hasRelatedWork W3181332544 @default.
• W2433636306 hasRelatedWork W4210601529 @default.

• next